Skin immune biomarker predicts the development of AD in the pediatric population
With a prevalence of 15-20%, atopic dermatitis (AD) is the most common skin disease in the pediatric population. At EADV 2022, The Barrier dysfunction in Atopic newBorns (BABY) study is ready to present results suggesting an essential role of immune biomarkers in predicting the development of AD during the first two years of life.
Brænder du for at skrive?
Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk
Send mail til redaktionen